2018 International Congress

Saturday, October 6, 2018

1:45pm-3:15pm

Multi-modal retention in a phase III clinical trial in early Parkinson disease (STEADY-PD III)

B. Greco, R. Holloway, K. Hodgeman, S. Henderson, C. Tarolli, K. Biglan, T. Simuni (Rochester, NY, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

Multimodal evoked potential analysis in Woodhouse-Sakati Syndrome

A.H. Abusrair, I. AlHamoud, S. Bohlega (Riyadh, Saudi Arabia)

Pathophysiology (Other Movement Disorders)  ·  Hall 3FG

1:45pm-3:15pm

Multimodal MRI markers modifications in multiple system atrophy: A longitudinal study

P. Péran, WG. Meissner, O. Rascol, A. Pavy-Le Traon (Toulouse, France)

Neuroimaging (Non-PD)  ·  Hall 3FG

1:45pm-3:15pm

Myoclonus in the pediatric age group: A retrospective analysis of clinical and electrophysiological characteristics of patients referred to an electrophysiology laboratory

A. Gunduz, H. Yılmaz, V. Demirbilek, C. Yalçınkaya, N. Yeni, S. Saltık, M. E. Kızıltan (Istanbul, Turkey)

Myoclonus  ·  Hall 3FG

1:45pm-3:15pm

Neurologic Wilson’s Disease: Case Series on a Diagnostic and Therapeutic Emergency

R. Porlas, L. De Castillo, C. Dioquino (Manila, Philippines)

Rare Genetic and Metabolic Diseases  ·  Hall 3FG

1:45pm-3:15pm

Neurological improvement with WTX101 treatment in a Phase 2, multi-center, open label study in Wilson Disease

D. Bega, J. Bronstein, D. Nicholl, F. Askari, A. Ala, P. Ferenci, C. Bjartmar, KH. Weiss, M. Schilsky, A. Czlonkowska (Chicago, IL, USA)

Rare Genetic and Metabolic Diseases  ·  Hall 3FG

1:45pm-3:15pm

Neuromelanin Imaging and Midbrain Volumetry in Progressive Supranuclear Palsy and Parkinson’s Disease

D. Taniguchi, T. Hatano, K. Kamagata, A. Okuzumi, M. Hori, S. Aoki, N. Hattori (Tokyo, Japan)

Neuroimaging (Non-PD)  ·  Hall 3FG

1:45pm-3:15pm

Neuromelanin-MRI in REM sleep behaviour disorder predicts dopaminergic dysfunction and clinical risk of Parkinson’s disease

T. Barber, L. Griffanti, K. Bradley, D. McGowan, M. Crabbe, C. Lo, C. Mackay, J. Klein, M. Hu (Oxford, United Kingdom)

Neuroimaging (Non-PD)  ·  Hall 3FG

1:45pm-3:15pm

Neuromodulatory propensity of Ginko biloba to offset rotenone induced behaviour and biochemical alteration

K. Rode, D. Khatri, M. Panchawadkar, P. Rane (Pune, India)

Neuropharmacology  ·  Hall 3FG

1:45pm-3:15pm

Neuromodulatory properties of flavonoids from Persea americana Peel: Role in CNS redox homeostasis and neurobehavioral markers

S. Grace SR, PR, J. Chauhan, G. Chandran (Mys, India)

Neuropharmacology  ·  Hall 3FG